CAS: 96068-42-7
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol REF: 3D-WDA06842CAS: 96068-42-7 | Min. 95% | 180,00 €~780,00 € | Qui 27 Fev 25 |
 | SARS-CoV-2-IN-32 REF: TM-T63181CAS: 96068-42-7 | - - - | 2.023,00 €~3.328,00 € | Qui 13 Mar 25 |
4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol
CAS:96068-42-7
Please enquire for more information about 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol including the price, delivery time and more detailed …
Fórmula:
C27H23N5O4
Pureza:
Min. 95%
Peso molecular:
481.5 g/mol
Ref: 3D-WDA06842
| 25mg | 338,00 € | ||
| 50mg | 357,00 € | ||
| 100mg | 522,00 € | ||
| 250mg | 780,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 27 de Fevereiro de 2025
SARS-CoV-2-IN-32
CAS:96068-42-7
SARS-CoV-2-IN-32 inhibits COVID-19 (Mpro; PDB: 6LU7) and has anti-cancer effects; useful for related research.
Fórmula:
C27H23N5O4
Cor e Forma:
Liquid
Peso molecular:
481.5
Ref: TM-T63181
| 25mg | 2.023,00 € | ||
| 50mg | 2.633,00 € | ||
| 100mg | 3.328,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 13 de Março de 2025
